Beijing Idmo Co.
Latest round
- Series A
Last raised
- Jan 2019
Total raised
- Undisclosed
Investors
- 1
About Beijing Idmo Co.
, Ltd. is a biotechnology company engaged in the development of innovative drug efficacy evaluation models. The company was founded by Dr.D. in Immunology from the Southern Illinois University School of Medicine, with postdoctoral experience at the Harvard Medical School-affiliated Immune Disease Institute. It has established a "Living Tumor Tissue Biobank" and collaborates with several top-tier hospitals in China for personalized cancer treatment. offers a range of products and services aimed at improving the drug development process. The company has developed three main types of models: Patient-derived xenograft (PDX) models that maintain the original state of tumor tissue for high similarity to human tumors. IdealImmune, a tumor immuno-evaluation platform using dual humanized mice models for preclinical evaluation of immunotherapies and CAR-T therapies. Liver humanized mouse models for the study of liver cancer and infectious hepatitis, as well as for drug metabolism and toxicology tests. These models are designed to provide precise clinical medication guidance and contribute to personalized treatment plans for cancer patients. The company generates revenue by providing its drug efficacy evaluation models and personalized treatment plans to pharmaceutical companies and healthcare institutions.
Who invested in Beijing Idmo Co.
1 investor across 1 round
See all investors in Beijing Idmo Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jan 10, 2019
Amount
Undisclosed
Investors
Questions about Beijing Idmo Co.
Who invested in Beijing Idmo Co.?
Beijing Idmo Co. has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Beijing Idmo Co. raised?
Beijing Idmo Co. has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Beijing Idmo Co. last raise money?
Beijing Idmo Co.'s most recent round on record is a Series A, in Jan 2019.
What does Beijing Idmo Co. do?
Beijing Idmo Co. is a healthcare specialists company.
Where is Beijing Idmo Co. headquartered?
Beijing Idmo Co. is headquartered in Beijing, China.
Which VCs invest in companies like Beijing Idmo Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back healthcare specialists companies at Beijing Idmo Co.'s stage. Their profiles are linked below.
VCs backing healthcare specialists startups at Series A
Raising like Beijing Idmo Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.